Key facts
- Notable investors include Hunan Lushan Technology Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Yayuan Stem Cell Bank
- ·The full record, as it builds
Funding rounds
No funding rounds for Yayuan Stem Cell Bank are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yayuan Stem Cell Bank
Provider of biological storage services intended for medical research and therapeutic applications. The company offers advanced cryogenic technology, traceable data handling, and compliance with regulatory frameworks, enabling the healthcare and biotechnology market to achieve improved reliability enhanced accessibility for clinical and scientific use, reduced risks in preservation, broader adaptability across regenerative medicine and cellular therapy, and sustained support for innovation through consistent quality assurance and scalable infrastructure for diverse medical and research environments.
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Yayuan Stem Cell Bank doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yayuan Stem Cell Bank shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yayuan Stem Cell Bank in its N-PORT filings yet. We sweep new filings monthly.